A detailed history of Marino, Stram & Associates LLC transactions in Amgen Inc stock. As of the latest transaction made, Marino, Stram & Associates LLC holds 4,797 shares of AMGN stock, worth $1.54 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
4,797
Previous 4,626 3.7%
Holding current value
$1.54 Million
Previous $1.33 Million 2.33%
% of portfolio
0.32%
Previous 0.35%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

BUY
$268.87 - $324.56 $45,976 - $55,499
171 Added 3.7%
4,797 $1.36 Million
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $8,693 - $9,807
34 Added 0.74%
4,626 $1.33 Million
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $20,115 - $24,974
92 Added 2.04%
4,592 $1.23 Million
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $53,781 - $63,595
-251 Reduced 5.28%
4,500 $999,000
Q1 2023

Apr 20, 2023

BUY
$225.79 - $275.2 $86,025 - $104,851
381 Added 8.72%
4,751 $1.15 Million
Q4 2022

Jan 19, 2023

BUY
$229.03 - $291.01 $25,880 - $32,884
113 Added 2.65%
4,370 $0
Q3 2022

Oct 17, 2022

BUY
$224.46 - $253.15 $55,217 - $62,274
246 Added 6.13%
4,257 $959,000
Q2 2022

Jul 15, 2022

SELL
$230.71 - $256.74 $692 - $770
-3 Reduced 0.07%
4,011 $976,000
Q1 2022

Apr 25, 2022

BUY
$219.27 - $242.57 $6,797 - $7,519
31 Added 0.78%
4,014 $971,000
Q4 2021

Jan 20, 2022

BUY
$198.88 - $227.6 $29,434 - $33,684
148 Added 3.86%
3,983 $896,000
Q3 2021

Oct 14, 2021

SELL
$212.27 - $248.7 $618,130 - $724,214
-2,912 Reduced 43.16%
3,835 $816,000
Q2 2021

Jul 22, 2021

BUY
$233.58 - $259.14 $779,456 - $864,750
3,337 Added 97.86%
6,747 $1.64 Million
Q1 2021

Apr 26, 2021

BUY
$221.91 - $258.6 $80,331 - $93,613
362 Added 11.88%
3,410 $848,000
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $65,779 - $78,331
304 Added 11.08%
3,048 $701,000
Q3 2020

Oct 22, 2020

BUY
$234.65 - $260.95 $29,096 - $32,357
124 Added 4.73%
2,744 $698,000
Q2 2020

Jul 20, 2020

BUY
$197.81 - $242.74 $155,083 - $190,308
784 Added 42.7%
2,620 $618,000
Q1 2020

May 05, 2020

BUY
$182.24 - $241.7 $34,078 - $45,197
187 Added 11.34%
1,836 $372,000
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $2,270 - $2,918
12 Added 0.73%
1,649 $398,000
Q2 2019

Jul 19, 2019

BUY
$166.7 - $195.41 $110,355 - $129,361
662 Added 67.9%
1,637 $302,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $41,600 - $46,892
230 Added 30.87%
975 $185,000
Q2 2018

Aug 14, 2018

BUY
$166.05 - $186.51 $9,464 - $10,631
57 Added 8.28%
745 $138,000
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $26,261 - $30,690
155 Added 29.08%
688 $117,000
Q4 2017

Mar 09, 2018

BUY
$168.79 - $188.59 $89,965 - $100,518
533
533 $93,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Marino, Stram & Associates LLC Portfolio

Follow Marino, Stram & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marino, Stram & Associates LLC with notifications on news.